These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7985306)

  • 1. An economic rationale for prostate cancer screening.
    Benoit RM; Naslund MJ
    Urology; 1994 Dec; 44(6):795-803. PubMed ID: 7985306
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational computed tomography screening in 2003.
    Forster BB; Mayo JR
    Can Assoc Radiol J; 2003 Feb; 54(1):14-7. PubMed ID: 12625078
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine's battle with cancer. Screening still key element of armamentarium.
    Long HJ
    Minn Med; 1992 Dec; 75(12):17-9. PubMed ID: 1470084
    [No Abstract]   [Full Text] [Related]  

  • 4. Cohort Study of Overutilization of Preventive Screening for Patients With Pancreatic Cancer.
    Fisher AV; Abbott DE; Fernandes-Taylor S; Havlena JA; Wang X; Shan Y; Lawson EH; Winslow ER; Weber SM; Schumacher JR
    Pancreas; 2018 Oct; 47(9):e65-e67. PubMed ID: 30199493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostatic examinations of mass groups and early detection of cancer of the prostate].
    Katayama T
    Hinyokika Kiyo; 1987 Oct; 33(10):1547-9. PubMed ID: 3445842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prostate cancer: diagnostic costs of screening transrectal US and digital rectal examination.
    Torp-Pedersen ST; Littrup PJ; Lee F; Mettlin C
    Radiology; 1988 Nov; 169(2):351-4. PubMed ID: 3140290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC; Mettlin CJ; Murphy GP
    J Urol; 1994 Nov; 152(5 Pt 2):1873-7. PubMed ID: 7523734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of mass screening for prostatic cancer].
    Nakagawa S
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():289-93. PubMed ID: 12599587
    [No Abstract]   [Full Text] [Related]  

  • 9. The lack of futility in screening for prostate cancer.
    Zincke H
    Minn Med; 1993 Feb; 76(2):7. PubMed ID: 8507233
    [No Abstract]   [Full Text] [Related]  

  • 10. The case for prostate cancer screening.
    Andriole GL
    Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Responsible cancer screening].
    Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
    Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and cost of prostate cancer early detection.
    Murphy GP
    CA Cancer J Clin; 1993; 43(3):133. PubMed ID: 8490755
    [No Abstract]   [Full Text] [Related]  

  • 13. [Screening for cancer].
    Caicoya Gómez-Morán M
    Aten Primaria; 1995 Oct; 16(7):441-4, 446-52. PubMed ID: 7495955
    [No Abstract]   [Full Text] [Related]  

  • 14. Voluntary screening program for prostate cancer: detection rate and cost.
    Abramson N; Cotton S; Eckels R; Baldock J
    South Med J; 1994 Aug; 87(8):785-8. PubMed ID: 7519789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: should we screen for prostate cancer?
    Harwood RH
    Age Ageing; 1994 Mar; 23(2):164-8. PubMed ID: 8023729
    [No Abstract]   [Full Text] [Related]  

  • 16. The European Screening Study for Prostate Cancer.
    Schröder FH
    Can J Oncol; 1994 Nov; 4 Suppl 1():102-5; discussion 106-9. PubMed ID: 8853501
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer: enthusiasm for screening.
    Kaye KW
    Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
    [No Abstract]   [Full Text] [Related]  

  • 18. Is prostate cancer screening analogous to lung cancer screening?
    Farkas A; Schneider D; Cummings KB; Ward WS
    JAMA; 1997 Apr; 277(14):1120; author reply 1121-2. PubMed ID: 9087461
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostatic cancer in Japan.
    Watanabe H
    Prog Clin Biol Res; 1988; 269():99-110. PubMed ID: 3134664
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost-benefit effect of mass screening for prostatic disease on national economy].
    Nakao M; Watanabe H
    Hinyokika Kiyo; 1987 Oct; 33(10):1542-6. PubMed ID: 2451407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.